NervGen Pharma appoints Michael Kelly as President & CEO

Apr. 10, 2023 9:13 AM ETNervGen Pharma Corp. (NGENF), NGEN:CABy: Pranav Ghumatkar, SA News Editor
  • NervGen Pharma (OTCQX:NGENF) has announced the appointment of Mr. Michael Kelly to the position of President & CEO effective April 10, 2023.
  • Mr. Kelly has also been appointed as a member of NervGen's Board of Directors.
  • Mr. Kelly currently serves on the Board of Directors of ARS Pharmaceuticals, which he joined in May 2019.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.